4
MARKET OVERVIEW
Allergy diagnostics market thrives on AI integration and mHealth, despite high costs and knowledge gaps.
42
4.2.1.1
HIGH INCIDENCE AND HEAVY ECONOMIC BURDEN OF ALLERGIC DISEASES
4.2.1.2
INCREASING AWARENESS ABOUT ALLERGIES
4.2.1.3
RISING ENVIRONMENTAL POLLUTION LEVELS
4.2.1.4
COVERAGE OF ALLERGY DIAGNOSIS UNDER HEALTH INSURANCE SCHEMES
4.2.2.1
PREMIUM COST OF ALLERGY DIAGNOSTIC INSTRUMENTS
4.2.2.2
LACK OF ADEQUATE KNOWLEDGE AND POOR IMPLEMENTATION OF ALLERGY TESTING METHODS
4.2.2.3
LIMITED ACCESS TO HEALTHCARE SERVICES
4.2.3.1
USE OF MHEALTH IN ALLERGY DIAGNOSIS
4.2.3.2
INTEGRATION OF ARTIFICIAL INTELLIGENCE IN ALLERGY DIAGNOSIS
4.2.4.1
SHORTAGE OF ALLERGISTS AND LACK OF TRAINING PROGRAMS
4.2.4.2
DIAGNOSTIC CHALLENGES IN ALLERGIC PATIENTS
4.3
UNMET NEEDS & WHITE SPACES
4.3.1
UNMET NEEDS IN ALLERGY DIAGNOSTIC MARKET
4.3.2
WHITE SPACE OPPORTUNITIES
4.4
INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.4.1
INTERCONNECTED MARKETS
4.4.2
CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Navigate competitive dynamics and emerging market opportunities in the evolving global allergy diagnostics industry.
52
5.1
PORTER’S FIVE FORCES ANALYSIS
5.1.1
INTENSITY OF COMPETITIVE RIVALRY
5.1.2
BARGAINING POWER OF SUPPLIERS
5.1.3
BARGAINING POWER OF BUYERS
5.1.4
THREAT OF SUBSTITUTES
5.1.5
THREAT OF NEW ENTRANTS
5.2
MACROECONOMIC OUTLOOK
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN GLOBAL IVD INDUSTRY
5.2.4
TRENDS IN GLOBAL IMMUNOASSAY INDUSTRY
5.3
SUPPLY CHAIN ANALYSIS
5.6.1
AVERAGE SELLING PRICE OF ALLERGY DIAGNOSTIC PRODUCTS, BY PRODUCT & SERVICE, 2025
5.6.2
AVERAGE SELLING PRICE TREND OF ALLERGY DIAGNOSTIC PRODUCTS, BY REGION, 2024–2026
5.7.1
IMPORT DATA FOR HS CODE 902750, 2020–2024
5.7.2
EXPORT DATA FOR HS CODE 902750, 2020–2024
5.8
KEY CONFERENCES & EVENTS, 2026–2027
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.10
INVESTMENT & FUNDING SCENARIO
5.11.1
EXPANDING ACCESS TO ALLERGY DIAGNOSTICS IN EMERGING MARKETS
5.11.2
SCALING HIGH-THROUGHPUT ALLERGY TESTING IN CENTRALIZED LABORATORIES
5.11.3
IMPROVING PEDIATRIC ALLERGY DIAGNOSIS THROUGH MULTIPLEX TESTING
5.12
IMPACT OF 2025 US TARIFF ON ALLERGY DIAGNOSTIC MARKET
5.12.3
PRICE IMPACT ANALYSIS
5.12.4
IMPACT ON COUNTRIES/REGIONS
5.12.5
END-USE INDUSTRY IMPACT
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
AI-driven innovations redefine allergy diagnostics, paving the way for personalized and automated solutions.
69
6.1
KEY EMERGING TECHNOLOGIES
6.1.1
SPECIFIC IGE IMMUNOASSAYS
6.1.2
SKIN PRICK TESTING (SPT)
6.2
COMPLEMENTARY TECHNOLOGIES
6.2.1
AUTOMATED IMMUNOASSAY ANALYZERS
6.3
TECHNOLOGY/PRODUCT ROADMAP
6.3.1
SHORT-TERM (2025–2027) | FOUNDATION & EARLY COMMERCIALIZATION
6.3.2
MID-TERM (2027–2030) | EXPANSION & STANDARDIZATION
6.3.3
LONG-TERM (2030–2035+) | MASS COMMERCIALIZATION & DISRUPTION
6.4.1
INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
6.5.1
ADVANCED MULTIPLEX AND PERSONALIZED ALLERGY DIAGNOSTICS
6.5.2
DIGITAL & AI-ENABLED ALLERGY MONITORING PLATFORMS
6.5.3
AI-INTEGRATED DIGITAL SURGICAL ECOSYSTEMS FOR IOLS
6.6
IMPACT OF AI/GEN AI ON ALLERGY DIAGNOSTIC MARKET
6.6.1
TOP USE CASES AND MARKET POTENTIAL
6.6.2
CASE STUDIES OF AI IMPLEMENTATION
6.6.3
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.6.4
CLIENTS’ READINESS TO ADOPT GENERATIVE AI
7
REGULATORY LANDSCAPE
Navigate complex global regulations with insights into regional compliance and industry standards.
78
7.1
REGIONAL REGULATIONS & COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Unlock market profitability by addressing unmet needs and stakeholder-driven buying criteria in allergy diagnostics.
81
8.1
DECISION-MAKING PROCESS
8.2
KEY STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2
KEY BUYING CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
8.5.3
MARGIN OPPORTUNITIES IN KEY APPLICATIONS
9
ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million and Units | 10 Data Tables
85
9.2.1
RECURRENT USE OF CONSUMABLES FOR ALLERGY DIAGNOSTICS TO DRIVE MARKET
9.3.1
IMMUNOASSAY ANALYZERS
9.3.1.1
HIGH PREFERENCE FOR TESTING TO BOOST MARKET DEMAND
9.3.2.1
CONVENIENCE AND EASE OF USE TO PROPEL MARKET GROWTH
9.4.1
RISING NEED TO ENSURE EFFECTIVE UTILIZATION OF ALLERGY DIAGNOSTIC PRODUCTS TO SUPPORT MARKET GROWTH
10
ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 8 Data Tables
95
10.2.1.1
SKIN PRICK TESTS TO BE MOST WIDELY PREFERRED IN VIVO ALLERGY TESTS
10.2.2.1
RAPID DIAGNOSIS OF CONTACT DERMATITIS TO BOOST MARKET DEMAND
10.2.3
OTHER IN VIVO TESTS
10.3.1
ABILITY TO IDENTIFY ALLERGEN-SPECIFIC IGE MOLECULES IN PATIENT SERUM TO DRIVE MARKET
11
ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 6 Data Tables
104
11.2.1
HIGH INCIDENCE OF ASTHMA TO BOOST MARKET GROWTH
11.3.1
HIGH PREVALENCE OF FOOD-RELATED ALLERGIES AMONG YOUNG CHILDREN TO SUPPORT MARKET GROWTH
11.4.1
INCREASING INCIDENCE OF DRUG ALLERGIES AND ADVERSE REACTIONS TO DRIVE MARKET
12
ALLERGY DIAGNOSTIC MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 5 Data Tables
111
12.2
HOSPITAL-BASED LABORATORIES
12.2.1
HOSPIATAL-BASED LABORATORIES TO BE MORE ACCESSIBLE TO PATIENTS AND OFFER RAPID RESULTS
12.3
DIAGNOSTIC LABORATORIES
12.3.1
DIAGNOSTIC LABORATORIES TO PIVOTAL FOR DIAGNOSIS AND MANAGEMENT OF ALLERGIES
12.4
ACADEMIC RESEARCH INSTITUTES
12.4.1
RISING NUMBER OF INSTITUTES FOR ALLERGY TESTING TRAINING TO SUPPORT MARKET GROWTH
13
ALLERGY DIAGNOSTIC MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 14 Countries | 143 Data Tables.
119
13.2.1.1
US TO DOMINATE NORTH AMERICAN ALLERGY DIAGNOSTIC MARKET
13.2.2.1
RISING FUNDING ACTIVITIES IN ALLERGY DIAGNOSTICS TO DRIVE MARKET
13.3.1.1
INCREASING PREVALENCE OF ALLERGIC CONDITIONS AND RISING PRESENCE OF ALLERGY DIAGNOSTIC PRODUCT MANUFACTURERS TO AID MARKET GROWTH
13.3.2.1
INCREASING PREVALENCE OF FOOD ANAPHYLAXIS TO SUPPORT MARKET GROWTH
13.3.3.1
INCREASING REIMBURSEMENTS FOR ALLERGY TESTING TO SPUR MARKET GROWTH
13.3.4.1
PRESENCE OF ALLERGY DIAGNOSTIC ORGANIZATIONS TO SUPPORT INCREASED DEMAND FOR PRODUCTS
13.3.5.1
GOVERNMENT INITIATIVES AND HEALTHCARE INFRASTRUCTURAL DEVELOPMENT TO DRIVE MARKET
13.4.1.1
RISING ALLERGY PREVALENCE AND GROWING RESEARCH ACTIVITIES TO AUGMENT MARKET GROWTH
13.4.2.1
INCREASING PREVALENCE OF ALLERGIES AMONG CHILDREN TO PROPEL DEMAND FOR ALLERGY DIAGNOSTICS
13.4.3.1
LIMITED AWARENESS REGARDING ALLERGY MANAGEMENT TO LIMIT MARKET GROWTH
13.4.4.1
RISING ALLERGY BURDEN AND HIGH DIAGNOSTIC UPTAKE TO FUEL SOUTH KOREAN MARKET GROWTH
13.4.5.1
HIGH PREVALENCE OF FOOD ALLERGIES AND MAJOR LIFESTYLE CHANGES TO DRIVE MARKET
13.4.6
REST OF ASIA PACIFIC
13.5.1.1
HIGH PREVALENCE OF CHILDHOOD ASTHMA TO AUGMENT MARKET GROWTH
13.5.2.1
GROWING FOCUS ON AWARENESS TRAINING PROGRAMS TO BOOST MARKET DEMAND
13.5.3
REST OF LATIN AMERICA
13.6
MIDDLE EAST & AFRICA
13.7.1
RISING HEALTHCARE SPENDING TO SPUR MARKET GROWTH
14
COMPETITIVE LANDSCAPE
Uncover strategic insights on market leaders and emerging players shaping future competitive dynamics.
183
14.2
KEY PLAYER STRATEGY/RIGHT TO WIN
14.3
REVENUE ANALYSIS, 2021–2025
14.4
MARKET SHARE ANALYSIS
14.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
14.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
14.5.5.1
COMPANY FOOTPRINT
14.5.5.2
REGION FOOTPRINT
14.5.5.3
PRODUCT & SERVICE FOOTPRINT
14.5.5.4
TEST TYPE FOOTPRINT
14.5.5.5
ALLERGEN FOOTPRINT
14.6
COMPETITIVE EVALUATION MATRIX: STARTUPS/SMES, 2025
14.6.1
PROGRESSIVE COMPANIES
14.6.2
RESPONSIVE COMPANIES
14.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
14.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
14.6.5.2
COMPETITIVE BENCHMARKING OF STARTUPS/SMES
14.7
COMPANY VALUATION & FINANCIAL METRICS
14.8
BRAND/PRODUCT COMPARISON
14.9
COMPETITIVE SCENARIO
14.9.1
PRODUCT LAUNCHES & APPROVALS
15
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
199
15.1.1
THERMO FISHER SCIENTIFIC INC.
15.1.1.1
BUSINESS OVERVIEW
15.1.1.2
PRODUCTS OFFERED
15.1.1.3
RECENT DEVELOPMENTS
15.1.1.3.1
PRODUCT LAUNCHES & APPROVALS
15.1.1.4.2
STRATEGIC CHOICES
15.1.1.4.3
WEAKNESSES & COMPETITIVE THREATS
15.1.2
DANAHER CORPORATION
15.1.3
SIEMENS HEALTHINEERS AG
15.1.4
CANON, INC. (MINARIS MEDICAL AMERICA, INC.)
15.1.5
REVVITY, INC. (EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG)
15.1.6
EUROFINS SCIENTIFIC
15.1.8
DSM ROYAL (ROMER LABS DIVISION HOLDING GMBH)
15.1.9
HOLLISTERSTIER ALLERGY (JUBILANT PHARMA)
15.1.10
OMEGA DIAGNOSTICS GROUP PLC
15.1.11
STALLERGENES GREER LTD.
15.2.1
HOB BIOTECH GROUP CORP., LTD.
15.2.3
LINCOLN DIAGNOSTICS, INC.
15.2.5
ASTRA BIOTECH GMBH
15.2.8
ACON LABORATORIES, INC.
15.2.9
ALCIT INDIA PVT. LTD.
15.2.10
BIOPANDA REAGENTS LTD.
15.2.12
CREATIVE DIAGNOSTIC MEDICARE PVT. LTD.
15.2.13
DST DIAGNOSTISCHE SYSTEME & TECHNOLOGIEN GMBH
15.2.14
DR. FOOKE LABORATORIEN GMBH
16
RESEARCH METHODOLOGY
236
16.1.1.1
KEY SECONDARY SOURCES
16.1.1.2
KEY DATA FROM SECONDARY SOURCES
16.1.2.1
OBJECTIVES OF PRIMARY RESEARCH
16.1.2.2
KEY DATA FROM PRIMARY SOURCES
16.1.2.3
KEY INDUSTRY INSIGHTS
16.1.2.4
BREAKDOWN OF PRIMARIES
16.2
MARKET SIZE ESTIMATION
16.2.1
SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
16.2.2
COMPANY INVESTOR PRESENTATIONS AND PRIMARY INTERVIEWS
16.2.4
DEMAND-SIDE ANALYSIS
16.4
MARKET SHARE ESTIMATION
16.7
RESEARCH LIMITATIONS
17.2
KNOWLEDGESTORE: MARKETSANDMARKETS. SUBSCRIPTION PORTAL
17.3
CUSTOMIZATION OPTIONS
TABLE 1
ALLERGY DIAGNOSTIC MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2
STANDARD CURRENCY CONVERSION RATES (USD)
TABLE 3
IMPACT OF PORTER’S FIVE FORCES IN ALLERGY DIAGNOSTIC MARKET
TABLE 4
GDP PERCENTAGE CHANGE, BY COUNTRY, 2021–2030
TABLE 5
AVERAGE SELLING PRICE OF ALLERGY DIAGNOSTIC PRODUCTS, BY PRODUCT & SERVICE, 2025 (USD)
TABLE 6
AVERAGE PRICING TREND OF ALLERGY DIAGNOSTIC PRODUCTS, BY REGION, 2024–2026 (USD)
TABLE 7
IMPORT DATA FOR HS CODE 902750, BY COUNTRY, 2020–2024 (USD THOUSAND)
TABLE 8
EXPORT DATA FOR HS CODE 902750, BY COUNTRY, 2020–2024 (USD THOUSAND)
TABLE 9
KEY MAJOR CONFERENCES AND EVENTS IN ALLERGY DIAGNOSTIC MARKET, JANUARY 2026–DECEMBER 2027
TABLE 10
CASE STUDY 1: EXPANDING ACCESS TO ALLERGY DIAGNOSTICS IN EMERGING MARKETS
TABLE 11
CASE STUDY 2: SCALING HIGH-THROUGHPUT ALLERGY TESTING IN CENTRALIZED LABORATORIES
TABLE 12
CASE STUDY 3: IMPROVING PEDIATRIC ALLERGY DIAGNOSIS THROUGH MULTIPLEX TESTING
TABLE 13
US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 14
KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR ALLERGY DIAGNOSTIC
TABLE 15
TOP USE CASES AND POTENTIAL IN ALLERGY DIAGNOSTIC MARKET
TABLE 16
CASE STUDIES RELATED TO AI IMPLEMENTATION IN ALLERGY DIAGNOSTIC MARKET
TABLE 17
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS IN ALLERGY DIAGNOSTIC MARKET
TABLE 18
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22
MIDDLE EAST & AFRICA AND GCC COUNTRIES: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23
GLOBAL STANDARDS IN ALLERGY DIAGNOSTIC MARKET
TABLE 24
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF ALLERGY DIAGNOSTIC PRODUCTS
TABLE 25
KEY BUYING CRITERIA FOR ALLERGY DIAGNOSTIC PRODUCTS
TABLE 26
UNMET NEEDS IN ALLERGY DIAGNOSTIC MARKET
TABLE 27
ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 28
ALLERGY DIAGNOSTIC CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 29
ALLERGY DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 30
ALLERGY DIAGNOSTIC INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 31
ALLERGY DIAGNOSTIC INSTRUMENTS MARKET FOR IMMUNOASSAY ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 32
ALLERGY DIAGNOSTIC INSTRUMENTS MARKET FOR IMMUNOASSAY ANALYZERS, BY REGION, 2024–2031 (UNITS)
TABLE 33
ALLERGY DIAGNOSTIC INSTRUMENTS MARKET FOR LUMINOMETERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 34
ALLERGY DIAGNOSTIC INSTRUMENTS MARKET FOR LUMINOMETERS, BY REGION, 2024–2031 (UNITS)
TABLE 35
OTHER ALLERGY DIAGNOSTIC INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 36
ALLERGY DIAGNOSTIC SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 37
ADVANTAGES AND LIMITATIONS OF ALLERGY TESTS
TABLE 38
ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
TABLE 39
ALLERGY DIAGNOSTIC MARKET FOR IN VIVO TESTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 40
ALLERGY DIAGNOSTIC MARKET FOR IN VIVO TESTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 41
ALLERGY DIAGNOSTIC MARKET FOR SKIN PRICK TESTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 42
ALLERGY DIAGNOSTIC MARKET FOR PATCH TESTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 43
ALLERGY DIAGNOSTIC MARKET FOR OTHER IN VIVO TESTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 44
ALLERGY DIAGNOSTIC MARKET FOR IN VITRO TESTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 45
ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2024–2031 (USD MILLION)
TABLE 46
ALLERGY DIAGNOSTIC MARKET FOR INHALED ALLERGENS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 47
SPECIFIC FOOD-INDUCED ALLERGIC CONDITIONS
TABLE 48
ALLERGY DIAGNOSTIC MARKET FOR FOOD ALLERGENS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 49
ALLERGY DIAGNOSTIC MARKET FOR DRUG ALLERGENS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 50
ALLERGY DIAGNOSTIC MARKET FOR OTHER ALLERGENS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 51
ALLERGY DIAGNOSTIC MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 52
ALLERGY DIAGNOSTIC MARKET FOR HOSPITAL-BASED LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 53
ALLERGY DIAGNOSTIC MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 54
ALLERGY DIAGNOSTIC MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 55
ALLERGY DIAGNOSTIC MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 56
ALLERGY DIAGNOSTIC MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 57
NORTH AMERICA: ALLERGY DIAGNOSTIC MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 58
NORTH AMERICA: ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 59
NORTH AMERICA: ALLERGY DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 60
NORTH AMERICA: ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
TABLE 61
NORTH AMERICA: ALLERGY DIAGNOSTIC MARKET FOR IN VIVO TESTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 62
NORTH AMERICA: ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2024–2031 (USD MILLION)
TABLE 63
NORTH AMERICA: ALLERGY DIAGNOSTIC MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 64
US: ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 65
US: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 66
US: ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
TABLE 67
US: ALLERGY DIAGNOSTIC MARKET FOR IN VIVO TESTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 68
US: ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2024–2031 (USD MILLION)
TABLE 69
US: ALLERGY DIAGNOSTIC MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 70
CANADA: ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 71
CANADA: ALLERGY DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 72
CANADA: ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
TABLE 73
CANADA: ALLERGY DIAGNOSTIC MARKET FOR IN VIVO TESTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 74
CANADA: ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2024–2031 (USD MILLION)
TABLE 75
CANADA: ALLERGY DIAGNOSTIC MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 76
EUROPE: ALLERGY DIAGNOSTIC MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 77
EUROPE: ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 78
EUROPE: ALLERGY DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 79
EUROPE: ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
TABLE 80
EUROPE: ALLERGY DIAGNOSTIC MARKET FOR IN VIVO TESTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 81
EUROPE: ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2024–2031 (USD MILLION)
TABLE 82
EUROPE: ALLERGY DIAGNOSTIC MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 83
GERMANY: ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 84
GERMANY: ALLERGY DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 85
GERMANY: ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
TABLE 86
GERMANY: ALLERGY DIAGNOSTIC MARKET FOR IN VIVO TESTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 87
GERMANY: ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2024–2031 (USD MILLION)
TABLE 88
GERMANY: ALLERGY DIAGNOSTIC MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 89
UK: ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 90
UK: ALLERGY DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 91
UK: ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
TABLE 92
UK: ALLERGY DIAGNOSTIC MARKET FOR IN VIVO TESTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 93
UK: ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2024–2031 (USD MILLION)
TABLE 94
UK: ALLERGY DIAGNOSTIC MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 95
FRANCE: ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 96
FRANCE: ALLERGY DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 97
FRANCE: ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
TABLE 98
FRANCE: ALLERGY DIAGNOSTIC MARKET FOR IN VIVO TESTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 99
FRANCE: ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2024–2031 (USD MILLION)
TABLE 100
FRANCE: ALLERGY DIAGNOSTIC MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 101
ITALY: ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 102
ITALY: ALLERGY DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 103
ITALY: ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
TABLE 104
ITALY: ALLERGY DIAGNOSTIC MARKET FOR IN VIVO TESTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 105
ITALY: ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2024–2031 (USD MILLION)
TABLE 106
ITALY: ALLERGY DIAGNOSTIC MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 107
SPAIN: ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 108
SPAIN: ALLERGY DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 109
SPAIN: ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
TABLE 110
SPAIN: ALLERGY DIAGNOSTIC MARKET FOR IN VIVO TESTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 111
SPAIN: ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2024–2031 (USD MILLION)
TABLE 112
SPAIN: ALLERGY DIAGNOSTIC MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 113
REST OF EUROPE: ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 114
REST OF EUROPE: ALLERGY DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 115
REST OF EUROPE: ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
TABLE 116
REST OF EUROPE: ALLERGY DIAGNOSTIC MARKET FOR IN VIVO TESTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 117
REST OF EUROPE: ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2024–2031 (USD MILLION)
TABLE 118
REST OF EUROPE: ALLERGY DIAGNOSTIC MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 119
ASIA PACIFIC: ALLERGY DIAGNOSTIC MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 120
ASIA PACIFIC: ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 121
ASIA PACIFIC: ALLERGY DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 122
ASIA PACIFIC: ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
TABLE 123
ASIA PACIFIC: ALLERGY DIAGNOSTIC MARKET FOR IN VIVO TESTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 124
ASIA PACIFIC: ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2024–2031 (USD MILLION)
TABLE 125
ASIA PACIFIC: ALLERGY DIAGNOSTIC MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 126
CHINA: ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 127
CHINA: ALLERGY DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 128
CHINA: ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
TABLE 129
CHINA: ALLERGY DIAGNOSTIC MARKET FOR IN VIVO TESTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 130
CHINA: ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2024–2031 (USD MILLION)
TABLE 131
CHINA: ALLERGY DIAGNOSTIC MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 132
JAPAN: ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 133
JAPAN: ALLERGY DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 134
JAPAN: ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
TABLE 135
JAPAN: ALLERGY DIAGNOSTIC MARKET FOR IN VIVO TESTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 136
JAPAN: ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2024–2031 (USD MILLION)
TABLE 137
JAPAN: ALLERGY DIAGNOSTIC MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 138
INDIA: ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 139
INDIA: ALLERGY DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 140
INDIA: ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
TABLE 141
INDIA: ALLERGY DIAGNOSTIC MARKET FOR IN VIVO TESTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 142
INDIA: ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2024–2031 (USD MILLION)
TABLE 143
INDIA: ALLERGY DIAGNOSTIC MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 144
SOUTH KOREA: ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 145
SOUTH KOREA: ALLERGY DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 146
SOUTH KOREA: ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
TABLE 147
SOUTH KOREA: ALLERGY DIAGNOSTIC MARKET FOR IN VIVO TESTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 148
SOUTH KOREA: ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2024–2031 (USD MILLION)
TABLE 149
SOUTH KOREA: ALLERGY DIAGNOSTIC MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 150
AUSTRALIA: ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 151
AUSTRALIA: ALLERGY DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 152
AUSTRALIA: ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
TABLE 153
AUSTRALIA: ALLERGY DIAGNOSTIC MARKET FOR IN VIVO TESTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 154
AUSTRALIA: ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2024–2031 (USD MILLION)
TABLE 155
AUSTRALIA: ALLERGY DIAGNOSTIC MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 156
REST OF ASIA PACIFIC: ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 157
REST OF ASIA PACIFIC: ALLERGY DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 158
REST OF ASIA PACIFIC: ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
TABLE 159
REST OF ASIA PACIFIC: ALLERGY DIAGNOSTIC MARKET FOR IN VIVO TESTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 160
REST OF ASIA PACIFIC: ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2024–2031 (USD MILLION)
TABLE 161
REST OF ASIA PACIFIC: ALLERGY DIAGNOSTIC MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 162
LATIN AMERICA: ALLERGY DIAGNOSTIC MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 163
LATIN AMERICA: ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 164
LATIN AMERICA: ALLERGY DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 165
LATIN AMERICA: ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
TABLE 166
LATIN AMERICA: ALLERGY DIAGNOSTIC MARKET FOR IN VIVO TESTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 167
LATIN AMERICA: ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2024–2031 (USD MILLION)
TABLE 168
LATIN AMERICA: ALLERGY DIAGNOSTIC MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 169
BRAZIL: ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 170
BRAZIL: ALLERGY DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 171
BRAZIL: ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
TABLE 172
BRAZIL: ALLERGY DIAGNOSTIC MARKET FOR IN VIVO TESTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 173
BRAZIL: ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2024–2031 (USD MILLION)
TABLE 174
BRAZIL: ALLERGY DIAGNOSTIC MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 175
MEXICO: ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 176
MEXICO: ALLERGY DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 177
MEXICO: ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
TABLE 178
MEXICO: ALLERGY DIAGNOSTIC MARKET FOR IN VIVO TESTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 179
MEXICO: ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2024–2031 (USD MILLION)
TABLE 180
MEXICO: ALLERGY DIAGNOSTIC MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 181
REST OF LATIN AMERICA: ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 182
REST OF LATIN AMERICA: ALLERGY DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 183
REST OF LATIN AMERICA: ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
TABLE 184
REST OF LATIN AMERICA: ALLERGY DIAGNOSTIC MARKET FOR IN VIVO TESTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 185
REST OF LATIN AMERICA: ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2024–2031 (USD MILLION)
TABLE 186
REST OF LATIN AMERICA: ALLERGY DIAGNOSTIC MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 187
MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 188
MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 189
MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
TABLE 190
MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTIC MARKET FOR IN VIVO TESTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 191
MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2024–2031 (USD MILLION)
TABLE 192
MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTIC MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 193
GCC COUNTRIES: ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 194
GCC COUNTRIES: ALLERGY DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 195
GCC COUNTRIES: ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE, 2024–2031 (USD MILLION)
TABLE 196
GCC COUNTRIES: ALLERGY DIAGNOSTIC MARKET FOR IN VIVO TESTS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 197
GCC COUNTRIES: ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN, 2024–2031 (USD MILLION)
TABLE 198
GCC COUNTRIES: ALLERGY DIAGNOSTIC MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 199
KEY DEVELOPMENTS IN ALLERGY DIAGNOSTIC MARKET, JANUARY 2021–JANUARY 2026
TABLE 200
ALLERGY DIAGNOSTIC MARKET: DEGREE OF COMPETITION
TABLE 201
ALLERGY DIAGNOSTIC MARKET: REGION FOOTPRINT
TABLE 202
ALLERGY DIAGNOSTIC MARKET: PRODUCT & SERVICE FOOTPRINT
TABLE 203
ALLERGY DIAGNOSTIC MARKET: TEST TYPE FOOTPRINT
TABLE 204
ALLERGY DIAGNOSTIC MARKET: ALLERGEN FOOTPRINT
TABLE 205
ALLERGY DIAGNOSTIC MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
TABLE 206
ALLERGY DIAGNOSTIC MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY PRODUCT & SERVICE AND REGION
TABLE 207
ALLERGY DIAGNOSTIC MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2026
TABLE 208
ALLERGY DIAGNOSTIC MARKET: DEALS, JANUARY 2021–JANUARY 2026
TABLE 209
ALLERGY DIAGNOSTIC MARKET: EXPANSIONS, JANUARY 2021–JANUARY 2026
TABLE 210
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 211
THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
TABLE 212
THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2026
TABLE 213
THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–JANUARY 2026
TABLE 214
DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 215
DANAHER CORPORATION: PRODUCTS OFFERED
TABLE 216
SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
TABLE 217
SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED
TABLE 218
CANON, INC. (MINARIS MEDICAL AMERICA, INC.): COMPANY OVERVIEW
TABLE 219
CANON, INC. (MINARIS MEDICAL AMERICA, INC.): PRODUCTS OFFERED
TABLE 220
CANON, INC. (MINARIS MEDICAL AMERICA, INC.): DEALS, JANUARY 2021–JANUARY 2026
TABLE 221
REVVITY, INC. (EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG): COMPANY OVERVIEW
TABLE 222
REVVITY, INC. (EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG): PRODUCTS OFFERED
TABLE 223
REVVITY, INC. (EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG): DEALS, JANUARY 2021–JANUARY 2026
TABLE 224
EUROFINS SCIENTIFIC: COMPANY OVERVIEW
TABLE 225
EUROFINS SCIENTIFIC: PRODUCTS OFFERED
TABLE 226
EUROFINS SCIENTIFIC: EXPANSIONS, JANUARY 2021–JANUARY 2026
TABLE 227
BIOMÉRIEUX SA: COMPANY OVERVIEW
TABLE 228
BIOMÉRIEUX SA: PRODUCTS OFFERED
TABLE 229
DSM ROYAL (ROMER LABS DIVISION HOLDING GMBH): COMPANY OVERVIEW
TABLE 230
DSM ROYAL (ROMER LABS DIVISION HOLDING GMBH): PRODUCTS OFFERED
TABLE 231
DSM ROYAL (ROMER LABS DIVISION HOLDING GMBH): DEALS, JANUARY 2021–JANUARY 2026
TABLE 232
HOLLISTERSTIER ALLERGY (JUBILANT PHARMA): COMPANY OVERVIEW
TABLE 233
HOLLISTERSTIER ALLERGY (JUBILANT PHARMA): PRODUCTS OFFERED
TABLE 234
OMEGA DIAGNOSTICS GROUP PLC: COMPANY OVERVIEW
TABLE 235
OMEGA DIAGNOSTICS GROUP PLC: PRODUCTS OFFERED
TABLE 236
STALLERGENES GREER LTD.: COMPANY OVERVIEW
TABLE 237
STALLERGENES GREER LTD.: PRODUCTS OFFERED
TABLE 238
STALLERGENES GREER LTD.: DEALS, JANUARY 2021–JANUARY 2026
TABLE 239
HOB BIOTECH GROUP CORP., LTD.: COMPANY OVERVIEW
TABLE 240
HYCOR BIOMEDICAL: COMPANY OVERVIEW
TABLE 241
LINCOLN DIAGNOSTICS, INC.: COMPANY OVERVIEW
TABLE 242
R-BIOPHARM AG: COMPANY OVERVIEW
TABLE 243
ASTRA BIOTECH GMBH: COMPANY OVERVIEW
TABLE 244
ERBA GROUP: COMPANY OVERVIEW
TABLE 245
AESKU.GROUP GMBH: COMPANY OVERVIEW
TABLE 246
ACON LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 247
ALCIT INDIA PVT. LTD.: COMPANY OVERVIEW
TABLE 248
BIOPANDA REAGENTS LTD.: COMPANY OVERVIEW
TABLE 249
BIOSIDE S.R.L.: COMPANY OVERVIEW
TABLE 250
CREATIVE DIAGNOSTIC MEDICARE PVT. LTD.: COMPANY OVERVIEW
TABLE 251
DST DIAGNOSTISCHE SYSTEME & TECHNOLOGIEN GMBH: COMPANY OVERVIEW
TABLE 252
DR. FOOKE LABORATORIEN GMBH: COMPANY OVERVIEW
TABLE 253
ALLERGY DIAGNOSTIC MARKET: STUDY ASSUMPTIONS
TABLE 254
ALLERGY DIAGNOSTIC MARKET: RISK ANALYSIS
FIGURE 1
ALLERGY DIAGNOSTIC MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2
ALLERGY DIAGNOSTIC MARKET: YEARS CONSIDERED
FIGURE 3
KEY INSIGHTS & MARKET HIGHLIGHTS
FIGURE 4
ALLERGY DIAGNOSTIC MARKET SIZE, 2026–2031 (USD MILLION)
FIGURE 5
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN ALLERGY DIAGNOSTIC MARKET
FIGURE 6
DISRUPTIVE TRENDS IMPACTING GROWTH OF ALLERGY DIAGNOSTIC MARKET
FIGURE 7
HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE, TEST TYPE, END USER, AND REGION (2025)
FIGURE 8
NORTH AMERICA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 9
INCREASING GOVERNMENT INITIATIVES AND RISING INVESTMENTS TO IMPROVE MARKET GROWTH
FIGURE 10
CHINA AND HOSPITAL-BASED LABORATORIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2025
FIGURE 11
INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 12
NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE FROM 2024 TO 2031
FIGURE 13
EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD
FIGURE 14
ALLERGY DIAGNOSTIC MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 15
ALLERGY DIAGNOSTIC MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 16
ALLERGY DIAGNOSTIC MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 17
ALLERGY DIAGNOSTIC MARKET: VALUE CHAIN ANALYSIS
FIGURE 18
ALLERGY DIAGNOSTIC MARKET: ECOSYSTEM ANALYSIS
FIGURE 19
TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS IN ALLERGY DIAGNOSTIC MARKET
FIGURE 20
FUNDING AND NUMBER OF DEALS IN ALLERGY DIAGNOSTIC MARKET (USD MILLION)
FIGURE 21
NUMBER OF PATENTS PUBLISHED IN ALLERGY DIAGNOSTIC MARKET, JANUARY 2016-JANUARY 2026
FIGURE 22
TOP APPLICANT COUNTRIES/REGIONS FOR ALLERGY DIAGNOSTIC (JANUARY 2015−JANUARY 2026)
FIGURE 23
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF ALLERGY DIAGNOSTIC PRODUCTS
FIGURE 24
KEY BUYING CRITERIA FOR ALLERGY DIAGNOSTIC PRODUCTS
FIGURE 25
NORTH AMERICA: ALLERGY DIAGNOSTIC MARKET SNAPSHOT
FIGURE 26
ASIA PACIFIC: ALLERGY DIAGNOSTIC MARKET SNAPSHOT
FIGURE 27
REVENUE ANALYSIS OF TOP PLAYERS IN ALLERGY DIAGNOSTIC MARKET, 2021–2025 (USD MILLION)
FIGURE 28
MARKET SHARE ANALYSIS OF KEY PLAYERS IN ALLERGY DIAGNOSTIC MARKET, 2025
FIGURE 29
ALLERGY DIAGNOSTIC MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 30
ALLERGY DIAGNOSTIC MARKET: COMPANY FOOTPRINT
FIGURE 31
ALLERGY DIAGNOSTIC MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 32
EV/EBITDA OF KEY VENDORS
FIGURE 33
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 34
ALLERGY DIAGNOSTIC MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 35
THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
FIGURE 36
DANAHER CORPORATION: COMPANY SNAPSHOT
FIGURE 37
SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT
FIGURE 38
CANON, INC. (MINARIS MEDICAL AMERICA, INC.): COMPANY SNAPSHOT
FIGURE 39
REVVITY, INC. (EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG): COMPANY SNAPSHOT
FIGURE 40
EUROFINS SCIENTIFIC: COMPANY SNAPSHOT
FIGURE 41
BIOMÉRIEUX SA: COMPANY SNAPSHOT
FIGURE 42
DSM ROYAL (ROMER LABS DIVISION HOLDING GMBH): COMPANY SNAPSHOT
FIGURE 43
HOLLISTERSTIER ALLERGY (JUBILANT PHARMA): COMPANY SNAPSHOT
FIGURE 44
OMEGA DIAGNOSTICS GROUP PLC: COMPANY SNAPSHOT
FIGURE 45
ALLERGY DIAGNOSTIC MARKET: RESEARCH DESIGN
FIGURE 46
ALLERGY DIAGNOSTIC MARKET: KEY DATA FROM SECONDARY SOURCES
FIGURE 47
ALLERGY DIAGNOSTIC MARKET: PRIMARY SOURCES
FIGURE 48
ALLERGY DIAGNOSTIC MARKET: KEY DATA FROM PRIMARY SOURCES
FIGURE 49
ALLERGY DIAGNOSTIC MARKET: KEY INSIGHTS FROM INDUSTRY EXPERTS
FIGURE 50
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY/DEMAND-SIDE PARTICIPANTS
FIGURE 51
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS, BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 52
BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS, BY END USER, DESIGNATION, AND REGION
FIGURE 53
ALLERGY DIAGNOSTIC MARKET SIZE ESTIMATION
FIGURE 54
REVENUE SHARE ANALYSIS ILLUSTRATION: THERMO FISHER SCIENTIFIC INC. (2025)
FIGURE 55
SUPPLY-SIDE ANALYSIS OF KEY PLAYERS IN ALLERGY DIAGNOSTIC MARKET (2025)
FIGURE 56
ALLERGY DIAGNOSTIC MARKET: TOP-DOWN APPROACH
FIGURE 57
ALLERGY DIAGNOSTIC MARKET: CAGR PROJECTIONS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2031)
FIGURE 58
ALLERGY DIAGNOSTIC MARKET: CAGR PROJECTIONS (SUPPLY-SIDE ANALYSIS)
FIGURE 59
ALLERGY DIAGNOSTIC MARKET: DATA TRIANGULATION
Mason
Jun, 2026
After reviewing the Allergy Diagnostics Market report, I found the breakdown of testing modalities and regional demand patterns particularly useful for evaluating where diagnostic labs can expand their service portfolios over the next few years..
Harper
Jun, 2026
I was interested in how the Allergy Diagnostics Market analysis connects advancements in immunoassay techniques with shifting clinical preferences, which helped me better understand the technical drivers behind test adoption..
Grayson
Jun, 2026
From a strategic standpoint, the Allergy Diagnostics Market insights gave me a clearer view of competitive positioning and investment opportunities, especially in emerging markets where allergy prevalence and diagnostic awareness are rising..